Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

Advertisment

Pulmicort, Budesonide News

News on Pulmicort, Budesonide (generic) continually updated from thousands of sources around the net.

May 31, 2009 | Drug Store News

Verus Pharmaceuticals files lawsuit against AstraZeneca

SAN DIEGO A pharmaceutical company focused on drugs for children has filed a lawsuit against Anglo-Swedish drug maker AstraZeneca.

Comment?

Related Topix: Biotech, Medicine, AstraZeneca Group, Healthcare Industry, New York Metro, Medication, Asthma, Health, Rhinocort, Budesonide (generic)

Fri May 29, 2009

Med Ad News

Verus Pharmaceuticals Announces a Lawsuit Against AstraZeneca AB and Tika Lakemedel AB

Verus Pharmaceuticals, Inc. , a specialty pharmaceutical company, announced today that it has filed a lawsuit against AstraZeneca AB and Tika Lakemedel AB in the Supreme Court of the State of New York, in which it is seeking $1.3 billion on claims of fraud, breach of contract, and conversion.

Comment?

Related Topix: New York, Medicine, Medication, Health, Asthma

Wed May 27, 2009

Medical News Today

Budesonide/formoterol Plus Tiotropium Improves The Quality Of Life Of Patients With Severe COPD

Main Category: COPD Also Included In: Respiratory / Asthma Article Date: 27 May 2009 - 5:00 PDT Preliminary results from a double-blind, randomised, multicentre trial among 660 patients with chronic obstructive pulmonary disease show that budesonide/formoterol plus tiotropium significantly improves disease control and patients' quality of life.1,2 ...

Comment?

Related Topix: Copd, Medicine, Health, Foradil, Formoterol (generic), Medication, Asthma, Chronic Obstructive Pulmonary Disease, Biotech, AstraZeneca Group

Mon May 25, 2009

MediLexicon

SYMBICORT(R) Added To Tiotropium Provided Clinically Significant...

Data presented at this year's American Thoracic Society congress, demonstrated that SYMBICORT added to SpirivaTM provided greater clinical improvements than tiotropium alone over a 12-week treatment period.1,2 Results of the CLIMB study showed that the occurrence of severe exacerbations was reduced by as much as 62 percent in patients where ...

Comment?

Related Topix: Foradil, Formoterol (generic), Medicine, Medication, Copd

Thu May 21, 2009

Health

Breathing Problems Common During Pregnancy

Asthma is a fairly common health problem for pregnant women, including some women who have never had it before.

Comment?

Related Topix: Medicine, Asthma, Food and Drug Administration

Wed May 20, 2009

Medical News

AstraZeneca granted preliminary injunction against Apotex in Pulmicort Respules patent litigation

On May 20, 2009, the US District Court for the District of New Jersey granted the request of AstraZeneca for an injunction barring Apotex from launching a generic version of AstraZeneca's Pulmicort Respules in the US.

Comment?

Related Topix: Medicine, Medication, Biotech, AstraZeneca Group, Healthcare Industry, Food and Drug Administration

Wed May 13, 2009

Med Ad News

MAP Pharmaceuticals to Present at the Deutsche Bank Securities 34th Annual Health Care Conference

MAP Pharmaceuticals, Inc. today announced that the company will present at the Deutsche BankSecurities 34th Annual Health Care Conference on Tuesday, May 19, 2009 at 2:35 p.m. in Boston, MA.

Comment?

Related Topix: MAP Pharmaceuticals, Startups, Medicine, Medication

Sun Apr 19, 2009

Bloomberg.com

AstraZeneca Wins Bid to Stop Apotex From Selling Generic Asthma Drug

AstraZeneca Plc , the U.K.a s second- biggest drugmaker, won a bid to temporarily block Apotex Inc.

Comment?

Related Topix: Biotech, Medicine, AstraZeneca Group, Healthcare Industry, Asthma, Health, Medication, Camden, NJ

Fri Apr 17, 2009

Med Ad News

Court Grants AstraZeneca Temporary Restraining Order Against Apotex...

On 16 April 2009, the US District Court for the District of New Jersey granted AstraZeneca's request for a temporary restraining order, barring Apotex from launching a generic version of AstraZeneca's PULMICORT RESPULES until further order of the court.

Comment?

Related Topix: Biotech, AstraZeneca Group, Medicine, Medication, Asthma, Health

Thu Apr 16, 2009

MediLexicon

Combination Formoterol And Budesonide As Maintenance And Reliever...

Traditionally inhaled treatment for asthma has been considered as preventer and reliever therapy.

Comment?

Related Topix: Medicine, Health, Asthma, Foradil, Formoterol (generic), Medication

Wed Apr 15, 2009

Medical News

Combination inhaler might simplify asthma treatment

People suffering from chronic asthma might have a new treatment option that allows them to manage their condition with a single prescribed inhaler that contains two medicines, according to a new review.

Comment?

Related Topix: Medicine, Asthma, Health, Medication, Foradil, Formoterol (generic)

Thu Apr 09, 2009

MediLexicon

AstraZeneca Receives FDA Complete Response Letter On Symbicort For...

Main Category: Respiratory / Asthma Also Included In: Pharma Industry / Biotech Industry AstraZeneca announced the company has received a Complete Response Letter from the US Food and Drug Administration for SYMBICORT pressurized metered dose inhaler for the long-term maintenance treatment of asthma in paediatric patients ages 6-11 years.

Comment?

Related Topix: Food and Drug Administration, Medicine, Asthma, Health, Medication, Foradil, Formoterol (generic), Copd, Chronic Obstructive Pulmonary Disease

Wed Apr 08, 2009

The Winnipeg Free Press

Police issue warning about prescription drugs taken in purse snatching

Winnipeg police have issued a warning about some prescription drugs taken in a purse snatching Saturday night from a female leaving a business in the 900 block of Jefferson Avenue.

Comment?

Related Topix: Medicine, Terbutaline (generic), Brethine, Travel

Tue Apr 07, 2009

Fox News

AstraZeneca Files Lawsuit Against Apotex

Drugmaker AstraZeneca said Tuesday that it has filed a lawsuit in the U.S. District Court for the District of New Jersey against Apotex seeking a declaration of patent infringement.

Comment?

Related Topix: Medicine, Medication, Business News

The Oregonian

FDA asks for more data on AstraZeneca's Symbicort, EU

The use of Symbicort for the long-term maintenance treatment of asthma is already approved for patients aged 12 and over in the United States and the company has applied to sell it for the same purpose for children aged six to 11.

Comment?

Related Topix: Biotech, Medicine, AstraZeneca Group, Healthcare Industry, Food and Drug Administration, Asthma, Health, Marketing, Medication

Mon Apr 06, 2009

International Business Times

Analysts optimistic on MAP Pharma's migraine trial

Results of a late-stage trial of MAP Pharmaceuticals Inc's inhaled migraine drug will represent a critical moment for the company given the recent failure of its other key drug to treat asthma in children.

Comment?

Related Topix: Migraine, Medicine, Health, Asthma, Medication

Fri Mar 13, 2009

Med Ad News

DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer

EWING, N.J., March 13, 2009 /PRNewswire-FirstCall/ DOR BioPharma, Inc. announced today that it has appointed Brian L. Hamilton, MD, PhD, as Senior Vice President and Chief Medical Officer.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Ewing, NJ, Beclomethasone (generic), Vanceril, QVAR, Medication, Immunology, Biology, Science, Rhinocort, Budesonide (generic)

Sat Mar 07, 2009

Nursing Center

Medication Error: Pulmicort Flexhaler dose confusion

AstraZeneca has received approval to update the patient instructions on its Pulmicort Flexhaler , thanks to nurses' reports on patient confusion with the device's dose counter.

Comment?

Related Topix: Medicine, Medication, Biotech, AstraZeneca Group, Healthcare Industry, Nursing

Fri Feb 27, 2009

Med Ad News

FDA Approves Symbicort for Chronic Obstructive Pulmonary Disease

The FDA approval is based on results from two pivotal clinical trials, SHINE and SUN , which found SYMBICORT significantly improved lung function within five minutes of the first dose and sustained that lung ...

Comment?

Related Topix: Copd, Medicine, Health, Chronic Obstructive Pulmonary Disease, Medication, Foradil, Formoterol (generic), Bronchitis, Emphysema

Tue Feb 24, 2009

BioWorld

MAP Phase III Asthma Study Fails to Hit Mark in Pediatric Patients

MAP Pharmaceuticals Inc. said that its potential treatment for asthma in children did not improve symptoms any better than placebo in a Phase III study of unit dose budesonide , leaving the program in limbo for ...

Comment?

Related Topix: Medicine, Asthma, Health, MAP Pharmaceuticals, Startups, Medication, Migraine

↑ Back to top

More Pulmicort, Budesonide News

Archives

Read more articles in the Pulmicort, Budesonide News Archives.

For up to the minute news, check out the Pulmicort, Budesonide News Wire.

Want to add Pulmicort, Budesonide News headlines to your web site? Get the widget here.

RSS icon mobile icon

Pulmicort, Budesonide (generic) Photos

Vote on and add your comments to the latest Pulmicort, Budesonide (generic) photos from around the world

Pulmicort, Budesonide News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make Pulmicort, Budesonide News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

Also on Topix